ENG and hepatocellular carcinoma: Due to the observation that endoglin (CD105) is selectively expressed (or overexpressed) in activated vascular ECs in tumours (including HCC), it was hypothesized that it can also be a useful target for vascular-targeted anti-angiogenic therapy [10].